Observational Prospective Registry of the Efficacy, Safety, and Adherence to Therapy of Infergen® (Interferon Alfacon 1) in Patients Chronically Infected With Hepatitis C Virus (REACH SVR)
This study has been terminated.
Sponsor:
Kadmon Pharmaceuticals
Information provided by:
Kadmon Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00951223
First received: August 3, 2009
Last updated: May 23, 2011
Last verified: May 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | April 2012 |
| Primary Completion Date: | November 2010 (Final data collection date for primary outcome measure) |